Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1F 18 T807----[2] 2, 127
2F-18----[2] 5, 127
3F-18 3F4AP----[1] 13
4F-18 AV 1451----[2] 5, 127
5F-18 FDG----[1] 127
6F-18 FEDAA1106 (BAY85-8101)----[1] 13
7F-18 FPCIT----[1] 6
8F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----[1] 299
9F13CD----[1] 288
10F18CETO----[1] 75
11F8IL10----[2] 46, 97
12F8VR----[1] 288
13FAB122----[1] 2
14FABRAZYME[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
15Fabrazyme (agalsidase beta)[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
16Fabrazyme (agalsidase beta) 1 mg/kg[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
17FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
18Fabrazyme 35 mg[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
19Fabrazyme 5 mg[1] Agalsidase beta[1] D03228 [1] GLA 💬[6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬[1] 19
20FACS analyses----[1] 65
21FACTANE 200 IU/ml----[1] 288
22Factor VIII[1] Beroctocog alfa---[1] 288
23Factor VIII concentrate[1] Beroctocog alfa---[1] 288
24Factor von Willebrand[1] Von Willebrand factor human---[1] 288
25FACTOR X[1] Coagulation factor X human---[1] 288
26Factor XIIa antagonist monoclonal antibody----[1] 85
27Factor XIII[1] Factor XIII (human)---[3] 51, 97, 288
28Factor XIII Concentrate (Human)[1] Factor XIII (human)---[1] 288
29Factor XIII Concentrate (Human), Pasteurized[1] Factor XIII (human)---[1] 288
30Faecal matter----[1] 97
31Faecal Microbiota Transplant----[1] 97
32Faecal microbiota transplantation----[5] 46, 84, 96, 97, 271
33Faecal sampling----[1] 46
34FAM Therapy----[1] 228
35FamC-1----[1] 2
36Famciclovir[1] Famciclovir[1] D00317 --[2] 11, 13
37FAMOTIDINA[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 61
38Famotidine[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[5] 6, 46, 86, 98, 107
39Famotidine 20 MG[1] Famotidine[1] D00318 [1] HRH2 💬[3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬[1] 86
40FAMPRIDINA[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
41FAMPRIDINE[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
42Fampridine SR[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
43Fampridine-SR[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
44Fampridine-SR b.i.d. (Twice Daily)[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
45FAMPYRA[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 13, 14
46FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)[1] Dalfampridine[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
47Fampyra 10 mg prolonged-release tablets[2] Dalfampridine,
Manganese citrate		[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
48Fampyra 10mg prolonged release tablets[2] Dalfampridine,
Manganese citrate		[1] D04127 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13
49Fang yi qing feng shi granule----[1] 46
50FANG(30)----[1] 46
51Fanhdi----[1] 288
52FANHDI 100 UI----[1] 288
53Fanhdi 100 UI FVIII-120 UI FVW----[1] 288
54FANHDI 25 UI----[1] 288
55Fanhdi 25 UI FVIII-30 UI FVW----[1] 288
56FANHDI 250UI*1F 250UI+F 10ML----[1] 288
57FANHDI 50 UI----[1] 288
58Fanhdi 50 UI FVIII-60 UI FVW----[1] 288
59FANHDI*INF FL 250UI+SIR SOLV+S----[1] 288
60FANHDI*INF FL 500UI+SIR SOLV+S----[1] 288
61FANHDI*INF FL1000UI+SIR SOLV+S----[1] 288
62FANHDI*INF FL250UI+SIR SOLV+S----[1] 288
63Fansidar (pyrimethamine and sulfadoxine)[2] Pyrimethamine,
Sulfadoxine		[2] D00488 ,
D00580 		--[1] 65
64Fasenra[1] Benralizumab[1] D09874 [1] IL5RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299
65Faslodex[1] Fulvestrant[1] D01161 [2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 49
66Fasudil[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 2, 5, 7, 51
67Fasudil (WP-0512)[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
68FASUDIL HYDROCHLORIDE[1] Fasudil[1] D07941 [2] ROCK1,
ROCK2 💬		[23] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
69Fat diet----[1] 78
70Fatigue----[1] 13
71FAXE Kondi----[1] 257
72Faxe Kondi Free----[1] 257
73Fazisiran Injection----[1] 231
74FB-101----[1] 6
75FB704A----[1] 46
76FBL-MTX----[1] 46
77FBS0701----[1] 284
78FBS0701 CAPSULE----[1] 284
79FBS0701/SSP004184----[1] 284
80FBX-101----[1] 19
81Fc- and CDR-modified humanised monoclonal antibody against C5----[3] 11, 62, 109
82FCM----[1] 222
83FCR001----[1] 51
84FCX-007----[1] 36
85FCX-013----[1] 51
86FDC macitentan/tadalafil[2] Macitentan,
Tadalafil		[2] D02008 ,
D10135 		[3] EDNRA,
EDNRB,
PDE5A 💬		[11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86
87FDG----[1] 84
88FDL169[1] FDL169---[1] 299
89FDL176----[1] 299
90FDL176 & FDL169 coadministration[1] FDL169---[1] 299
91FE 992097----[1] 193
92FE 999301----[2] 96, 97
93Feburane----[1] 21
94Febuxostat[1] Febuxostat[1] D01206 [1] XDH 💬[6] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬[3] 2, 6, 13
95Fecal Microbial transplant----[2] 96, 97
96Fecal microbial transplant (FMT)----[1] 13
97Fecal Microbial Transplantation----[2] 96, 97
98Fecal Microbial Transplants----[1] 13
99Fecal microbiota----[3] 13, 96, 97
100Fecal microbiota capsule----[1] 97
101Fecal Microbiota Enema----[1] 97
102Fecal Microbiota Transplant----[2] 96, 97
103Fecal Microbiota Transplant (FMT)----[2] 96, 97
104Fecal microbiota transplantation----[5] 2, 66, 94, 96, 97
105Fecal Microbiota Transplantation (FMT)----[2] 96, 97
106Fecal Microbiota Transplantation (FMT), OpenBiome----[1] 97
107Fecal Microbiota Transplantation by Intra-rectal enemas----[1] 97
108Fecal Microbiota Transplantation by Stool capsules----[1] 97
109Fecal transplantation----[1] 97
110Felzartamab[1] Felzartamab---[2] 66, 222
111Femoston 1/10----[1] 13
112Femoston 2/10----[1] 13
113Fendrix[1] Hepatitis B Vaccine (Recombinant)---[1] 46
114Fendrix suspension for injection[1] Hepatitis B Vaccine (Recombinant)---[1] 46
115Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).[1] Hepatitis B Vaccine (Recombinant)---[1] 46
116FENEBRUTINIB[1] Fenebrutinib[1] D11457 [1] BTK 💬[7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13
117Fenfluramina[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[2] 140, 144
118Fenfluramina Cloridrato[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[2] 140, 144
119FENFLURAMINE[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[4] 140, 144, 145, 149
120Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[1] 144
121FENFLURAMINE HYDROCHLORIDE[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[2] 140, 144
122FENFLURAMINE HYDROCHLORIDE (colorless)[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[2] 140, 144
123FENFLURAMINE HYDROCHLORIDE (red)[1] Fenfluramine[1] D07945 [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[1] 140
124Fengshigutong Capsule----[1] 271
125Fengshigutong Capsule plus Imrecoxib[1] Imrecoxib---[1] 271
126Fenilbutirato----[1] 2
127Fenofibrate[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[6] 8, 79, 93, 94, 97, 265
128Fenofibrate 160mg[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 97
129Fenofibrate 200mg[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
130Fenofibrate Combined With Ursodeoxycholic Acid[2] Fenofibrate,
Ursodeoxycholic acid		[2] D00565 ,
D00734 		[2] NR1H4,
PPARA 💬		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
131Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93
132Fenretinide[1] Fenretinide[1] D04162 [2] RARA,
RARB 💬		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 299
133Fentanyl[1] Fentanyl[1] D00320 [1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[3] 46, 70, 215
134Fentanyl (High Dose)[1] Fentanyl[1] D00320 [1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 215
135Fentanyl (Low Dose)[1] Fentanyl[1] D00320 [1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 215
136Fentanyl (Low Dose) + Dexmedetomidine[2] Dexmedetomidine,
Fentanyl		[2] D00320 ,
D00514 		[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215
137Fentanyl transdermal patch[1] Fentanyl[1] D00320 [1] OPRM1 💬[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬[1] 46
138Feraheme[1] Ferumoxytol[1] D04177 --[1] 13
139Ferinject----[2] 86, 299
140Ferinject or CosmoFer----[1] 86
141Fermented oyster extract[1] Oyster---[1] 84
142Ferric Carboxy Maltose[1] Maltose[1] D00044 --[1] 96
143FERRIC CARBOXYMALTOSE[1] Ferric carboxymaltose[1] D08920 --[4] 86, 96, 97, 299
144Ferric Maltol[1] Ferric maltol[1] D10833 --[1] 96
145Ferricarboxymaltose----[1] 86
146Ferriprox[1] Deferiprone[1] D07416 --[2] 6, 120
147Ferriprox 500 mg[1] Deferiprone[1] D07416 --[1] 6
148FERRIPROX*100CPR RIV 500MG[1] Deferiprone[1] D07416 --[1] 120
149Ferrograd----[1] 46
150Ferrograd Folic Tablets----[1] 46
151Ferrous sulfate 325mg[1] Sulfate ion---[1] 299
152Ferrous sulphate----[2] 96, 97
153Ferrous sulphate 200mg oral tablet----[1] 227
154Ferrprox (Deferiprone)[1] Deferiprone[1] D07416 --[1] 6
155Ferulic acid[1] Ferulic acid---[1] 127
156Ferumoxytol[1] Ferumoxytol[1] D04177 --[1] 13
157Fesoterodine[1] Fesoterodine[1] D07226 [2] CHRM2,
CHRM3 💬		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6
158Fetal porcine cells, Neurocell-PD----[1] 6
159Fexinidazole[1] Fexinidazole[1] D11252 --[1] 65
160Fexofenadine[1] Fexofenadine[1] D07958 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[2] 13, 46
161FFP104----[2] 93, 96
162FG-3019----[3] 85, 113, 222
163FG-3019 10mg/mL in 10 mL vials----[1] 85
164Fibrate treatment----[1] 160
165Fibrin[1] Fibrin---[1] 279
166Fibrinogen[1] Fibrinogen human---[2] 14, 65
167Fibrinogen (coagulation factorI)[1] Fibrinogen human---[1] 65
168Fibrinogen concentrate[1] Fibrinogen human---[1] 14
169Fibrinogen Concentrate from Human Plasma[1] Fibrinogen human---[1] 65
170Fibroblasts----[1] 36
171Fibrogammin P----[1] 288
172Fibrogammin® 1250----[1] 51
173Fibrogammin® P----[1] 288
174Fibrogammin®P----[1] 288
175Fibrogammin®P, coagulation factor XIII concentrate (Human)[1] Factor XIII (human)---[1] 51
176Fibrovein----[1] 279
177Fibrovein 3%----[1] 279
178Fig[1] Fig---[1] 2
179Filamentous haemagglutinin[1] Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---[1] 46
180Filamentous haemagglutinin adsorbed[1] Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)---[1] 46
181FILGOTINIB[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[6] 46, 53, 96, 97, 222, 271
182Filgotinib 200mg/day[1] Filgotinib[1] D10871 [1] JAK1 💬[27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46
183Filgrastim[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[28] 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331
184Filgrastim (G-CSF)[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 331
185Filgrastim Hexal[1] Filgrastim[1] D03235 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 65
186Filgrastim, Alemtuzumab[2] Alemtuzumab,
Filgrastim		[2] D02802 ,
D03235 		[2] CD52,
CSF3R 💬		[6] , Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 65
187Film-coated tablet----[1] 97
188Finamine tablets----[1] 6
189Finasteride[1] Finasteride[1] D00321 [1] SRD5A2 💬[3] Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬[1] 6
190Finely ground flaxseed powder[1] Flax seed---[1] 299
191Fingolimob----[1] 13
192Fingolimob (FTY)----[1] 13
193FINGOLIMOD[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[3] 13, 14, 156
194Fingolimod (FTY720)[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 156
195Fingolimod 0.5 mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
196Fingolimod 0.5mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
197Fingolimod 1.25 mg[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 13
198FINGOLIMOD HYDROCHLORIDE[1] Fingolimod[1] D10001 [1] S1PR1 💬[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[2] 13, 14
199Fingolimodi----[1] 13
200Fingolmod----[1] 13
201Fipamezole[1] Fipamezole---[2] 6, 17
202Fipamezole hydrochloride[1] Fipamezole---[2] 6, 17
203Fipamezole hydrochloride 30 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
204Fipamezole hydrochloride 60 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
205Fipamezole hydrochloride 90 mg oral disintegrating tablets[1] Fipamezole---[2] 6, 17
206Fipamezole ODT[1] Fipamezole---[1] 6
207Fipamezole ODT Cohort 2[1] Fipamezole---[1] 6
208Firategrast[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
209Firategrast (USAN approved name)[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
210Firategrast 150 mg[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
211Firategrast 300 mg[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
212Firategrast gastro-retentive solution[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
213Firategrast immediate release tablet[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
214Firategrast modified release tablet[1] Firategrast[1] D06590 [1] ITGA4 💬[14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬[1] 13
215Firdapse[1] Amifampridine[1] D10228 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 3, 11
216FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE[1] Amifampridine[1] D10228 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 3, 11
217First line DMT----[1] 13
218Fisetin[1] Fisetin---[1] 65
219Fish Oil[1] Fish oil---[8] 13, 46, 49, 66, 96, 260, 294, 299
220Fish oil concentrate[1] Fish oil---[1] 13
221Fish oil supplement[1] Fish oil---[1] 46
222Fish oil, gamma-linolenic acid[3] Fish oil,
Gamolenic acid,
alpha-Linolenic acid		[1] D07213 --[1] 46
223FISH OIL, RICH IN OMEGA-3-ACIDS[2] Fish oil,
Omega-3 fatty acids		---[1] 13
224FISH OIL,RICH IN OMEGA 3 ACIDS[1] Fish oil---[1] 13
225FITC-Adalimumab[1] Adalimumab[1] D02597 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97
226Fixed dose combination Ciprofloxacin/Celecoxib[2] Celecoxib,
Ciprofloxacin		[2] D00186 ,
D00567 		[1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 2
227FK-506----[1] 60
228FK506----[1] 222
229FK506 level 2-3 ng/ml----[1] 86
230FK506 level 3-5 ng/ml----[1] 86
231FK506 level < 2 ng/ml----[1] 86
232FKB327----[1] 46
233FKB327 AI----[1] 46
234FKB327 PFS----[1] 46
235Flagyl[1] Metronidazole[1] D00409 --[2] 96, 97
236Flavocoxid----[1] 113
237Flavoxate[1] Flavoxate[1] D07961 [16] PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬		[18] Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
238Flaxseed[1] Flax seed---[2] 97, 299
239Flaxseed lignan-enriched complex (FLC)[1] Flax seed---[1] 97
240FLEBOGAMMA 5%----[1] 15
241Flebogamma 5% DIF----[1] 65
242Flecainide[1] Flecainide[1] D07962 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
243FLECAINIDE ACETATE[2] Acetate,
Flecainide		[1] D07962 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
244Flecainidum[1] Flecainide[1] D07962 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
245Flixabi[1] Infliximab[1] D02598 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97
246Flolan[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
247FLOLAN injection with currently marketed diluent[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
248FLOLAN injection with reformulated diluent[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
249FLOLAN TM and Glycine Diluent[2] Epoprostenol,
Glycine		[2] D00011 ,
D00106 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
250Flolan®[1] Epoprostenol[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
251FLOLAN™ and Glycine Diluent[2] Epoprostenol,
Glycine		[2] D00011 ,
D00106 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
252FLORBETABEN (18F)[1] Florbetaben (18F)---[1] 6
253Florbetapir (18F)[1] Florbetapir (18F)---[1] 127
254Florbetapir 18F----[1] 127
255Florbetapir 18F Injection----[1] 127
256Florbetapir F 18----[1] 6
257Florence 30 µg/mL----[1] 98
258Florence 60 µg/mL----[1] 98
259Florence 90 µg/mL----[1] 98
260Flortaucipir[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
261Flortaucipir F18[1] Flortaucipir[1] D11210 [1] MAPT 💬[4] Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[3] 5, 7, 127
262Floseal----[1] 227
263Flovent----[1] 98
264FLT190----[1] 19
265FLT201----[1] 19
266Flu-ATG----[1] 60
267Flucinolone acetonide----[1] 56
268FLUCLOXACILLIN[1] Flucloxacillin[1] D04196 --[1] 299
269Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution[1] Flucloxacillin[1] D04196 --[1] 299
270FLUCLOXACILLIN SODIUM[1] Flucloxacillin[1] D04196 --[1] 299
271Flucloxicillin----[1] 299
272FLUCONAZOLE[1] Fluconazole[1] D00322 --[2] 96, 225
273FLUDARA[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13
274Fludarabina[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 19, 65
275Fludarabina Accord[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 65
276FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 19
277FLUDARABINA FOSFATO[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 19
278FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 65
279Fludarabine[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[19] 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326
280Fludarabine (FLU)[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 60, 285
281Fludarabine monophosphate[1] Fludarabine[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[3] 65, 284, 326
282Fludarabine phosphate[2] Fludarabine,
Phosphate ion		[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[12] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286
283Fludarabine phosphate 30 mg[2] Fludarabine,
Phosphate ion		[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 164
284Fludarabine phosphate 40 mg[2] Fludarabine,
Phosphate ion		[1] D07966 [1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[2] 65, 164
285Fludarabine, Busulfan, Thymoglobulin[3] Antithymocyte immunoglobulin (rabbit),
Busulfan,
Fludarabine		[2] D00248 ,
D07966 		[1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 65
286Fludarabine, Cyclophosphamide[2] Cyclophosphamide,
Fludarabine		[3] D00287 ,
D07760 ,
D07966 		[1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60
287Fludarabine, Melphalan, Thiotepa[3] Fludarabine,
Melphalan,
Thiotepa		[3] D00369 ,
D00583 ,
D07966 		[1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 65
288Fludarabine/ melphalan[2] Fludarabine,
Melphalan		[2] D00369 ,
D07966 		[1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60
289Fludarabine/busulfan[2] Busulfan,
Fludarabine		[2] D00248 ,
D07966 		[1] RRM1 💬[6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 60
290Fludeoxyglucose[1] Fludeoxyglucose[1] D01843 --[3] 84, 85, 88
291Fludrocortisone[1] Fludrocortisone[1] D07967 [1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81
292Fluimucil----[4] 85, 94, 193, 298
293Fluimucil (acetylcysteine)[1] Acetylcysteine[1] D00221 --[1] 193
294FLUIMUCIL*20CPR EFF 600MG----[2] 94, 298
295Fluimucil® 600 mg effervescent tablets----[1] 85
296Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[5] 6, 13, 17, 18, 206
297FluMist[1] Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---[1] 299
298Flumist®[1] Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---[1] 299
299Fluocinolone[1] Fluocinolone---[1] 90
300Fluocinolone Acetonide[2] Fluocinolone,
Fluocinolone acetonide		[1] D01825 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 90
301Fluorescein[1] Fluorescein[1] D01261 --[2] 22, 97
302Fluorescence in situ hybridization----[1] 285
303Fluorescite----[1] 215
304FLUORINE (18F) FLUDEOXYGLUCOSE[1] Fludeoxyglucose[1] D01843 --[2] 84, 85
305FLUORINE-18[1] Fluorine F-18[1] D05860 --[1] 41
306Fluorodeoxyglucose----[1] 84
307Fluoxetin[1] Fluoxetine[1] D00326 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[3] 13, 179, 206
308Fluoxetin Hexal[1] Fluoxetine[1] D00326 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
309FLUOXETINE[1] Fluoxetine[1] D00326 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[4] 13, 17, 78, 86
310FLUOXETINE HYDROCHLORIDE[1] Fluoxetine[1] D00326 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 13
311Fluoxétine[1] Fluoxetine[1] D00326 [1] SLC6A4 💬[2] Serotonergic synapse, Synaptic vesicle cycle 💬[1] 17
312Flupentixol[1] Flupentixol[1] D01044 [2] DRD1,
DRD2 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 97
313Flupirtin----[1] 13
314Flupirtine[1] Flupirtine[1] D07978 --[1] 13
315Flupirtinmaleat----[1] 13
316FLURBIPROFEN[1] Flurbiprofen[1] D00330 [2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[3] 13, 21, 46
317Flutamide[1] Flutamide[1] D00586 [1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 81
318Flutemetamol[1] Flutemetamol (18F)---[4] 5, 6, 7, 127
319Fluticasone[1] Fluticasone[1] D07981 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 98, 228, 299
320Fluticasone MDI[1] Fluticasone[1] D07981 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
321FLUTICASONE PROPIONATE[1] Fluticasone propionate[1] D01708 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 98, 228
322Fluticasone Propionate, USP[2] Fluticasone,
Fluticasone propionate		[2] D01708 ,
D07981 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
323Fluvastatin[1] Fluvastatin[1] D07983 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 79, 218, 222
324Fluzone[1] Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---[2] 21, 49
325Fluzone®[1] Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated)---[1] 21
326FLX-787-ODT----[1] 2
327FLX-787-ODT (orally disintegrating tablet)----[1] 10
328FLX-787-ODT (orally disintigrating tablet)----[1] 2
329FMP-30----[1] 53
330FMP30 Donor Stool----[1] 13
331FMT----[2] 96, 97
332FMT enema----[1] 97
333FMT infusions----[1] 97
334FMT oral----[1] 97
335Focetria----[1] 46
336Focetria (Monovalent MF59-Adjuvanted vaccine)----[3] 46, 49, 271
337Folate[1] Folic acid[1] D00070 --[3] 41, 46, 49
338FolateScan (Technetium Tc 99mEC20)----[4] 13, 46, 49, 96
339Folic (or folinic) acid----[1] 46
340Folic acid[1] Folic acid[1] D00070 --[5] 6, 46, 49, 84, 296
341Folic acid (non-investigational product)[1] Folic acid[1] D00070 --[1] 46
342Folic acid or folate[1] Folic acid[1] D00070 --[1] 46
343Folic Acid, Vitamin B6, Vitamin B12[3] Cyanocobalamin,
Folic acid,
Pyridoxine		[6] D00070 ,
D00166 ,
D03615 ,
D03616 ,
D03617 ,
D08454 		--[1] 6
344Folic/folinic acid[1] Leucovorin[2] D07986 ,
D07987 		--[2] 46, 107
345Foliglurax[1] Foliglurax---[1] 6
346Foliglurax 10 mg (treatment A)[1] Foliglurax---[1] 6
347Foliglurax 30 mg (treatment B)[1] Foliglurax---[1] 6
348Folimet----[1] 46
349Folinic acid[1] Leucovorin[2] D07986 ,
D07987 		--[3] 46, 107, 320
350Follow-up study of the treated cohort----[1] 193
351Fontolizumab[1] Fontolizumab[1] D04242 [1] IFNG 💬[32] African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 46
352Foralumab[1] Foralumab---[2] 13, 96
353Fordadistrogene movaparvovec[1] Fordadistrogene movaparvovec---[1] 113
354Forigerimod[1] Forigerimod[1] D09904 --[1] 49
355FORLAX 4 g, poudre pour solution buvable en sachet----[1] 299
356Formistin----[1] 13
357FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----[1] 13
358Formistin 10 mg----[1] 13
359Formoterol[1] Formoterol[1] D07990 [1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 85, 228, 299
360Formoterol fumarate dihydrate[1] Formoterol[1] D07990 [1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
361Formoterol/Budesonide[2] Budesonide,
Formoterol		[2] D00246 ,
D07990 		[2] ADRB2,
NR3C1 💬		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
362Formulation A----[1] 13
363Formulation B----[1] 13
364Formulation C----[1] 13
365Formulation D----[1] 13
366Forsteo[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[3] 70, 235, 274
367FORSTEO-R[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
368FORTECORTIN----[2] 28, 65
369Fortecortin Inject 40 mg Amp.----[1] 65
370Forteo[1] Teriparatide[1] D06078 [1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 70
371Fortiral----[1] 6
372Fortum----[1] 299
373Forxiga[1] Dapagliflozin[1] D08897 [1] SLC5A2 💬-[2] 86, 88
374Forxiga (dapagliflozin)[1] Dapagliflozin[1] D08897 [1] SLC5A2 💬-[2] 86, 88
375FOS----[2] 66, 96
376Foscarbidopa[1] Foscarbidopa[1] D12057 --[1] 6
377Foscarbidopa and Foslevodopa[2] Foscarbidopa,
Foslevodopa		[2] D11839 ,
D12057 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
378Foscarnet[1] Foscarnet---[1] 60
379FosD----[1] 46
380Fosfamatinib Disodium----[1] 46
381Fosfato sodico de dexametasona[1] Dexamethasone[1] D00292 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
382Fosfomycin[1] Fosfomycin[1] D04253 --[2] 96, 97
383FOSFOMYCIN DISODIUM[1] Fosfomycin[1] D04253 --[1] 97
384Foslevodopa[1] Foslevodopa[1] D11839 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
385Fosmetpantotenate----[1] 120
386Fosmetpantotenate (RE-024)----[1] 120
387FOSMETPANTOTENATE DRUG SUBSTANCE----[1] 120
388Fosmetpantotenato----[1] 120
389Fospropofol[1] Fospropofol---[1] 226
390Fospropofol (Lusedra®) 10[1] Fospropofol---[1] 226
391Fospropofol (Lusedra®) 12[1] Fospropofol---[1] 226
392Fospropofol (Lusedra®) 6.5[1] Fospropofol---[1] 226
393Fostair----[1] 85
394Fostamatinib[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[4] 46, 49, 61, 66
395Fostamatinib 100 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
396Fostamatinib 100 mg tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
397Fostamatinib 150 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
398Fostamatinib 150 mg bid[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 61
399Fostamatinib 150 mg tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
400Fostamatinib 50 mg blue film-coated tablet[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 46
401Fostamatinib Disodium[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[3] 46, 61, 66
402Fostamatinib Disodium (R935788)[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[2] 46, 49
403Fostamatinib Disodium tablet 100 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
404Fostamatinib Disodium tablet 150 mg[1] Fostamatinib[1] D09347 [1] SYK 💬[17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 66
405FP-110----[1] 97
406FP-CYA-050----[1] 97
407FP-CYA-053----[1] 97
408FPA008----[1] 46
409FPF 300 (thalidomide)[1] Thalidomide[1] D00754 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
410FPF1011----[1] 263
411FPF1100NW----[1] 6
412FPFS-1169----[1] 6
413FPI-2620----[1] 127
414FR104----[1] 46
415Fragmin[1] Dalteparin---[1] 222
416Frameshift Array blood sample test----[1] 34
417Free amino acids intake[1] Amino acids---[1] 240
418Freeze-dried black raspberry powder[1] Raspberry[1] D09179 --[1] 97
419Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)[1] Human immunoglobulin G---[3] 14, 43, 45
420Fremanezumab[1] Fremanezumab[1] D11055 [1] CALCA 💬[2] Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[2] 124, 226
421Fresenius-Kabi)----[1] 46
422Fresh Frozen Plasma----[1] 5
423Fresolimumab[1] Fresolimumab[1] D09620 [3] TGFB1,
TGFB2,
TGFB3 💬		[35] AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬[2] 51, 222
424Frisium----[1] 140
425FRISIUM*30CPS 10MG----[1] 140
426FRM-0334----[1] 127
427From August 2020 'no additional treatment'----[1] 51
428Frondanol----[1] 97
429Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----[1] 19
430FSME-IMMUN----[1] 46
431FT011----[1] 51
432FT011 100 mg----[1] 51
433FT011 200 mg----[1] 51
434FTI, AZLI----[1] 299
435FTX-1821----[1] 113
436FTY720----[2] 13, 14
437FTY720D----[1] 13
438FTY720I----[1] 14
439Fucidin[1] Fusidic acid[1] D04281 --[1] 299
440Fucidin Tablets[1] Fusidic acid[1] D04281 --[1] 299
441Fucose[1] Fucose---[1] 65
442Fully human anti-interferon gamma monoclonal antibody[1] Interferon Gamma---[1] 107
443Fully human IgG1 monoclonal antibody specific for TL1A----[2] 96, 97
444Fully human IgG2 lambda monoclonal antibody----[1] 172
445Fully human monoclonal antibody directed against CXCL10----[1] 93
446Fully humanised, recombinant monoclonal antibody (IgG1)----[1] 96
447Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----[1] 13
448Fultium-D3 800IU capsules----[1] 274
449Fulvestrant[1] Fulvestrant[1] D01161 [2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 86
450Fumaderm----[1] 49
451Fumaderm®----[1] 49
452Fumaderm® initial----[1] 49
453Fumaric acid[1] Fumaric acid[1] D02308 --[1] 13
454FURESTEM-RA Inj----[1] 46
455FURESTEM-RA Inj.----[1] 46
456Furosemide[1] Furosemide[1] D00331 [1] SLC12A2 💬[3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[2] 6, 86
457Furosemide Injection[1] Furosemide[1] D00331 [1] SLC12A2 💬[3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 6
458Fusidate[1] Fusidic acid[1] D04281 --[1] 299
459FUSIDIC ACID[1] Fusidic acid[1] D04281 --[1] 299
460Fusidin----[1] 299
461Fusion[1] Iron polymaltose---[7] 11, 13, 46, 49, 69, 70, 271
462Fuzhenghuayu----[1] 93
463Fx-1006A[1] Fx-1006A---[1] 28
464FX125L----[1] 46
465FXIIa inhibitor monoclonal antibody----[1] 85
466FXIII Concentrate (Human)----[1] 288
467FXIII Concentrate (Human) (FXIII)----[1] 288
468Fycompa[1] Perampanel[1] D08964 [4] GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		[16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[2] 2, 144